GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
1.36
-0.09 (-6.21%)
At close: Aug 15, 2025, 3:59 PM
1.36
-0.37%
After-hours: Aug 15, 2025, 06:10 PM EDT
GT Biopharma Fail-to-Deliver
Total FTD Shares
10.43K
Below Average
FTD / Avg. Volume
10.74%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
GT Biopharma Inc. has
10,434
shares failed to deliver, representing 10.74%
of the average daily volume of
97,148
shares. Over the past year, the monthly average FTD is
6,388
shares, with the current level 63% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 2.14 | 10.43K | +70.63% |
| Jun 30, 2025 | 3.58 | 6.12K | +28.60% |
| May 30, 2025 | 2.58 | 4.75K | +894.77% |
| Apr 23, 2025 | 2.23 | 478 | +378.00% |
| Mar 31, 2025 | 2.15 | 100 | -98.62% |
| Feb 28, 2025 | 2.38 | 7.23K | +66.89% |
| Jan 27, 2025 | 2.04 | 4.33K | +353.98% |
| Dec 31, 2024 | 3.05 | 954 | -31.07% |
| Nov 29, 2024 | 2.8 | 1.38K | +382.23% |
| Oct 30, 2024 | 3.01 | 287 | +229.89% |
| Sep 24, 2024 | 2 | 87 | -62.66% |
| Aug 16, 2024 | 2.25 | 233 | -34.73% |
| Jul 22, 2024 | 2.71 | 357 | -97.33% |
| Jun 28, 2024 | 2.83 | 13.37K | +568.25% |
| May 29, 2024 | 3.53 | 2K | +87.27% |
| Apr 23, 2024 | 3.65 | 1.07K | +233.75% |
| Mar 26, 2024 | 4.4 | 320 | +31900.00% |
| Feb 29, 2024 | 4.22 | 1 | -99.94% |
| Jan 30, 2024 | 6.3 | 1.66K | -91.58% |
| Dec 22, 2023 | 7.81 | 19.71K | +302.00% |
| Nov 15, 2023 | 7.2 | 4.9K | -74.23% |
| Oct 31, 2023 | 7.47 | 19.02K | +14201.50% |
| Sep 29, 2023 | 7.23 | 133 | -70.31% |
| Aug 03, 2023 | 7.86 | 448 | +1345.16% |
| Jul 24, 2023 | 8.97 | 31 | -99.82% |
| Jun 23, 2023 | 9.15 | 16.92K | -41.94% |
| May 26, 2023 | 8.63 | 29.14K | +8948.76% |
| Apr 28, 2023 | 11.41 | 322 | +78.89% |
| Mar 16, 2023 | 16.81 | 180 | -11.33% |
| Feb 22, 2023 | 18.6 | 203 | +84.55% |
| Jan 11, 2023 | 30 | 110 | n/a |